Clinical Trial Update: Pembrolizumab and Imatinib in Patients With Locally Advanced/Metastatic Melanoma With c-KIT Mutation/Amplification [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports that the Phase 1/2 study of pembrolizumab in combination with imatinib for locally advanced or metastatic melanoma with c-KIT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Imatinib (imatinib)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Joanne Jeter | Conditions: Stage IIIA Skin Melanoma, Stage IIIB Skin Melanoma | Phase 1, Phase 2 | Status: WITHDRAWN